BioHarvest Sciences: Funding, Investors & Team (Sep 2026)
BioHarvest Sciences produces and sells a food-based nutraceutical product called ViniaTM. It is the first and only industrial large-scale plant cell growth technology capable of directly and constantly producing the active plant ingredients without the necessity to grow the plant itself. By adopting this technology and building adequate cell production capacity, BioHarvest Sciences’ objective is to become the leading supplier of Cannabis for both medicinal and recreational legal use.
BioHarvest Sciences has raised $12.3M across 2 funding rounds on record, the most recent a Post-IPO Debt of $7.3M announced in Oct 2022.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BioHarvest Sciences Company Profile and Key Stats
Latest funding round on record: Oct 2022.
BioHarvest Sciences Funding Rounds
BioHarvest Sciences raised $5.0M in a Post-IPO Debt announced in Apr 2022.
6 months later, a Post-IPO Debt of $7.3M was announced in Oct 2022.
BioHarvest Sciences Founders and Leadership Team
No contact details are on record for this team yet.
BioHarvest Sciences Funding Compared to Other Biotechnology Startups
BioHarvest Sciences' latest round of $7.3M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BioHarvest Sciences in Biotechnology and Vancouver
Companies Similar to BioHarvest Sciences
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
BioHarvest Sciences Funding FAQs
What does BioHarvest Sciences do?
BioHarvest Sciences produces and sells a food-based nutraceutical product called ViniaTM. It is the first and only industrial large-scale plant cell growth technology capable of directly and constantly producing the active plant ingredients without the necessity to grow the plant itself. By adopting this technology and building adequate cell production capacity, BioHarvest Sciences’ objective is to become the leading supplier of Cannabis for both medicinal and recreational legal use.
How much funding has BioHarvest Sciences raised?
BioHarvest Sciences has raised $12.3M across 2 rounds on record. The most recent is a Post-IPO Debt of $7.3M announced in Oct 2022.
When did BioHarvest Sciences last raise funding?
BioHarvest Sciences' most recent funding round on record is a Post-IPO Debt of $7.3M, announced in Oct 2022.
Who is the CEO of BioHarvest Sciences?
Yochi Hagay is listed as CEO at BioHarvest Sciences.
Where is BioHarvest Sciences headquartered?
BioHarvest Sciences is based in Vancouver, British Columbia, Canada.
How many employees does BioHarvest Sciences have?
BioHarvest Sciences is in the 11-50 employee band.
How does BioHarvest Sciences' funding compare to other Biotechnology startups?
BioHarvest Sciences' latest round of $7.3M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's BioHarvest Sciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BioHarvest Sciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.